Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 July 2020: Database Analysis

Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response

Jiahua Lu 1234BCE , Shenyu Wei 5BCD , Jianying Lou 6BF , Shengyong Yin 1234DF , Lin Zhou 1234CD , Wu Zhang 78AEG* , Shusen Zheng 1234AEG*

DOI: 10.12659/MSM.925733

Med Sci Monit 2020; 26:e925733

Supplementary Table 1 Multivariate Cox regression analysis for alternative splicing (AS) events in each predictive model.

TypeAS eventCoefHR95% lower95% UpP-value
AAMRPL4|47484|AA−8.023.30E-042.68E-084.040.095098
ITGB1BP1|52617|AA−1.510.220.041.210.081335
CYB561A3|16164|AA−2.160.120.030.490.003402
SWI5|87732|AA2.5112.270.69216.660.087002
CELF1|15763|AA−2.940.053.59E-030.780.032441
EML3|16362|AA−9.348.82E-054.39E-091.770.064770
PLCG1|59390|AA−6.082.29E-035.51E-050.090.001375
C19orf33|49601|AA−8.142.91E-044.23E-070.200.014598
SRSF7|53281|AA5.00149.151.821.22E+040.026008
IGSF8|8426|AA12.853.83E+0591.051.61E+090.002530
SLC15A4|93374|AA−1.590.200.031.510.119692
ADCDK11A|218|AD−3.190.042.25E-030.750.031458
SUPT4H1|42666|AD−14.973.16E-074.77E-112.09E-030.000853
NFATC4|26993|AD−4.080.029.09E-040.310.006114
CLASRP|50392|AD−2.220.119.80E-031.210.070738
RAB15|27923|AD−1.260.280.081.060.061960
PTHLH|20910|AD1.957.011.7927.350.005089
NDUFAF2|72172|AD−6.182.08E-032.30E-050.190.007177
CCDC58|66432|AD−13.829.95E-075.96E-101.66E-030.000262
APS100A13|7733|AP−5.056.40E-031.66E-040.250.006691
UBA1|88907|AP4.78118.671.011.39E+040.049376
COPS7A|19933|AP2.108.161.1657.640.035306
UBE2L6|15862|AP13.941.13E+061.598.09E+110.042642
SH3KBP1|88641|AP−1.360.260.061.200.083722
SLC7A8|26712|AP2.178.731.3755.770.022006
EIF5A|38908|AP3.6036.480.941414.490.053957
ATVRK3|51144|AT2.098.100.51128.400.137897
RHOF|24898|AT5.72305.263.212.90E+040.013794
CDCA3|19984|AT−4.260.014.28E-040.470.016996
DOCK10|57781|AT−8.961.28E-046.29E-070.030.000949
ZNF506|48683|AT−3.630.031.49E-030.470.013505
ESCTNND1|15980|ES−1.160.310.091.110.072179
CTNND1|15958|ES−2.190.110.020.710.020238
CTAGE5|27377|ES−5.086.20E-032.13E-040.180.003117
UAP1|8750|ES6.59725.5810.874.84E+040.002116
NCAPH|54528|ES−11.511.00E-052.19E-084.58E-030.000230
GSE1|37883|ES−1.460.230.060.860.028096
CASP8|56821|ES−6.821.09E-031.10E-050.110.003605
MERAD51|30020|ME−3.240.044.58E-043.330.152682
RBM39|59248|ME−3.120.040.010.250.000410
ICA1|97384|ME−5.225.40E-031.80E-040.160.002600
TCF7L2|151705|ME−4.030.021.31E-042.430.108170
AMT|64866|ME7.261428.931.191.71E+060.044545
CERS5|21668|ME2.088.011.2352.280.029715
DNM2|47588|ME4.75115.114.193162.600.004994
RISPAG7|38626|RI−12.533.63E-064.86E-110.270.028648
CYB561A3|16163|RI−4.659.58E-037.33E-051.250.061473
TMEM9|9354|RI−1.320.270.080.920.036773
HTATIP2|14711|RI−1.930.140.020.840.031768
KRT15|40913|RI−1.520.220.050.900.035230
ALLS100A13|7733|AP−4.689.29E-032.66E-040.320.009853
SH3KBP1|88643|AP1.052.870.919.070.073418
CDCA3|19984|AT−2.950.051.82E-031.520.086090
COPS7A|19933|AP2.4211.201.6177.900.014633
UBE2L6|15862|AP15.435.01E+062.161.16E+130.039109
SON|60435|AT−6.491.52E-035.80E-060.400.022398
AA – alternate acceptor site; AD – alternate donor site; AP – alternate promoter; AT – alternate terminator; ES – exon skipping; HR – hazard ratio; ME – mutually exclusive exons; RI – retained intron.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750